Study published in Clinical Cancer Research cites important progress towards new treatments for cancer using PharmaJet Tropis
The campaign, sponsored by the World Health Organization as part of its polio eradication efforts, vaccinated 500,000 children, aged 4 – 59 months, over a one-week period in early 2019. Data on acceptability of the PharmaJet Tropis Needle-Free Injection System was collected from 610 vaccinators and 4,898 caregivers. Of those with prior needle and syringe experience, both vaccinators (97.6%) and caregivers (99.6%) expressed a strong preference for the Tropis system, citing ease and speed of use, appearance, and children’s response to the vaccination (less crying/discomfort). Among caregivers, 94.7% said they would be more likely to bring their child for vaccination in a future campaign that used jet injectors. Importantly, average vaccine coverage among towns administering fIPV was 98.7%, which was an increase of 18.4% over the preceding campaign for those areas.
The paper, entitled Needle-free injectors for mass administration of fractional dose inactivated poliovirus vaccine in Karachi, Pakistan: A survey of caregiver and vaccinator acceptability (Daly et al, 2020), was published in Vaccine on January 23, 2020.
Related posts
